Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib

V. Sandova, GM. Pavlasova, V. Seda, KA. Cerna, S. Sharma, V. Palusova, Y. Brychtova, S. Pospisilova, SM. Fernandes, A. Panovska, M. Doubek, MS. Davids, JR. Brown, J. Mayer, M. Mraz

. 2021 ; 106 (11) : 2995-2999. [pub] 20211101

Jazyk angličtina Země Itálie

Typ dokumentu dopisy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019646

Grantová podpora
802644 European Research Council - International
R01 CA213442 NCI NIH HHS - United States

000      
00000naa a2200000 a 4500
001      
bmc22019646
003      
CZ-PrNML
005      
20220804135848.0
007      
ta
008      
220720s2021 it f 000 0|eng||
009      
AR
024    7_
$a 10.3324/haematol.2021.278644 $2 doi
035    __
$a (PubMed)34196167
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Sandova, Veronika $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib / $c V. Sandova, GM. Pavlasova, V. Seda, KA. Cerna, S. Sharma, V. Palusova, Y. Brychtova, S. Pospisilova, SM. Fernandes, A. Panovska, M. Doubek, MS. Davids, JR. Brown, J. Mayer, M. Mraz
650    _2
$a antigeny CD20 $x metabolismus $7 D018951
650    12
$a antitumorózní látky $x terapeutické užití $7 D000970
650    _2
$a lidé $7 D006801
650    _2
$a interleukin-4 $7 D015847
650    12
$a chronická lymfatická leukemie $x farmakoterapie $7 D015451
650    _2
$a puriny $x farmakologie $x terapeutické užití $7 D011687
650    _2
$a chinazolinony $x farmakologie $x terapeutické užití $7 D052999
650    _2
$a transkripční faktor STAT6 $7 D050800
655    _2
$a dopisy $7 D016422
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pavlasova, Gabriela Mladonicka $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Seda, Vaclav $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Cerna, Katerina Amruz $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Sharma, Sonali $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Palusova, Veronika $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Brychtova, Yvona $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Pospisilova, Sarka $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Fernandes, Stacey M $u Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
700    1_
$a Panovska, Anna $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Doubek, Michael $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Davids, Matthew S $u Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
700    1_
$a Brown, Jennifer R $u Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
700    1_
$a Mayer, Jiri $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Mraz, Marek $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic. marek.mraz@email.cz
773    0_
$w MED00001963 $t Haematologica $x 1592-8721 $g Roč. 106, č. 11 (2021), s. 2995-2999
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34196167 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135841 $b ABA008
999    __
$a ok $b bmc $g 1823024 $s 1170889
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 106 $c 11 $d 2995-2999 $e 20211101 $i 1592-8721 $m Haematologica $n Haematologica $x MED00001963
GRA    __
$a 802644 $p European Research Council $2 International
GRA    __
$a R01 CA213442 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace